As we move through 2026, the Irish biopharma sector is navigating an unprecedented convergence of complex science, volatile geopolitics, and supply chain constraints. Despite having mature Quality Risk Management (QRM) and EHSS frameworks, many organisations continue to experience recurring operational and supply chain threats.
BioPharmaChem Ireland (BPCI) is launching a new Operational Risk Management Working Group in September to strengthen operational resilience and risk management culture across the Irish Biopharmachem sector. Designed for senior leaders and experienced professionals in operations, manufacturing, and supply chain, this working forum focuses on real-world outcomes and lived experiences rather than theoretical templates.
The group aims to elevate risk management from standard business consideration to strategic enabler, making operational resilience a competitive advantage for the Irish BioPharma sector.